Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autophagy01:27

Autophagy

4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Autophagic Cell Death01:18

Autophagic Cell Death

3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
The Proteasome01:13

The Proteasome

816
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
816
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Karyoptosis mediates cell death and neurodegeneration upon proteotoxic stress.

Nature communications·2026
Same author

First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

Journal of inherited metabolic disease·2026
Same author

Reply to: Mathematical Comments on Linking Neurofilament Light Chain Levels to Disease Severity in Hereditary Spastic Paraplegia Subtypes SPG11 and SPG15.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Pathogenic variants in the autophagy-tethering factor EPG5 drive neurodegeneration through mitochondrial dysfunction and innate immune activation.

Nature communications·2026
Same author

EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders.

European journal of human genetics : EJHG·2026
Same author

Genotype-structure-phenotype correlations define divergent natural history in early-onset spastic paraplegia type 4.

Brain : a journal of neurology·2026
Same journal

Biallelic Loss-Of-Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2025

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

31.2K

An update on autophagy disorders.

Hormos Salimi Dafsari1,2, Diego Martinelli3, Afshin Saffari4

  • 1Department of Pediatrics and Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Journal of Inherited Metabolic Disease
|October 18, 2024
PubMed
Summary
This summary is machine-generated.

Congenital autophagy disorders, caused by gene defects, present with neurological and multi-organ issues. Research is advancing understanding of these conditions and potential therapies.

Keywords:
autophagycellular traffickingcongenital disordersneurodegenerationneurodevelopment

More Related Videos

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

10.1K
Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.2K

Related Experiment Videos

Last Updated: Jun 10, 2025

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

31.2K
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

10.1K
Activating Autophagy by Aerobic Exercise in Mice
08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.2K

Area of Science:

  • Cell Biology
  • Genetics
  • Clinical Medicine

Background:

  • Macroautophagy is crucial for cellular homeostasis, especially in post-mitotic tissues.
  • Defects in autophagy genes lead to congenital disorders with shared clinical features like neurodevelopmental and neurodegenerative issues.
  • Vici syndrome, caused by EPG5 gene defects, is a key example of a congenital autophagy disorder.

Purpose of the Study:

  • To review autophagy in relation to intracellular trafficking.
  • To describe congenital autophagy disorders, their clinical signatures, and recommended health surveillance.
  • To discuss recent molecular mechanisms and future therapeutic strategies.

Main Methods:

  • Literature review of autophagy pathways and associated genetic disorders.
  • Analysis of clinical and genetic data from identified autophagy-related diseases.
  • Synthesis of current research on pathophysiology and therapeutic development.

Main Results:

  • Identification of numerous autophagy-associated disease genes beyond core machinery.
  • Expansion of the spectrum of congenital autophagy disorders linking selective autophagy and vesicular trafficking.
  • Enhanced understanding of pathophysiology providing a basis for therapy development.

Conclusions:

  • Congenital disorders of autophagy represent a significant clinical and molecular spectrum.
  • Advances in basic research are crucial for understanding disease mechanisms and developing therapies.
  • Primary health surveillance protocols are essential for managing these rare genetic conditions.